Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of long-term outcomes, cytogenetic and molecular responses with imatinib mesylate in early and late chronic-phase chronic myeloid leukemia: a report from a single institute.
Bendit I, Sanabani SS, Conchon M, Serpa M, Novaes MM, Nardinelli L, Pereira TD, Tucunduva L, Ferreira Pde B, Dorlhiac-Llacer PE, Fischer Chamone Dde A. Bendit I, et al. Among authors: tucunduva l. Acta Haematol. 2012;128(4):223-32. doi: 10.1159/000339696. Epub 2012 Aug 22. Acta Haematol. 2012. PMID: 22922489 Clinical Trial.
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation.
Tucunduva L, Ruggeri A, Sanz G, Furst S, Cornelissen J, Linkesch W, Mannone L, Ribera JM, Veelken H, Yakoub-Agha I, González Valentín ME, Schots R, Arcese W, Montesinos P, Labopin M, Gluckman E, Mohty M, Rocha V. Tucunduva L, et al. Br J Haematol. 2014 Sep;166(5):749-57. doi: 10.1111/bjh.12970. Epub 2014 Jun 25. Br J Haematol. 2014. PMID: 24961645 Free article.
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Tucunduva L, Ruggeri A, Sanz G, Furst S, Socié G, Michallet M, Arcese W, Milpied N, Yakoub-Agha I, Linkesch W, Cornelissen J, Mannone L, Iori AP, Ribera JM, Sanz J, Montesinos P, Purtill D, Labopin M, Gluckman E, Mohty M, Rocha V. Tucunduva L, et al. Bone Marrow Transplant. 2014 Jul;49(7):887-94. doi: 10.1038/bmt.2014.72. Bone Marrow Transplant. 2014. PMID: 24986801
Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases.
Tucunduva L, Volt F, Cunha R, Locatelli F, Zecca M, Yesilipek A, Caniglia M, Güngör T, Aksoylar S, Fagioli F, Bertrand Y, Addari MC, de la Fuente J, Winiarski J, Biondi A, Sengeloev H, Badell I, Mellgren K, de Heredia CD, Sedlacek P, Vora A, Rocha V, Ruggeri A, Gluckman E; Eurocord and the EBMT Paediatric working party. Tucunduva L, et al. Br J Haematol. 2015 Apr;169(1):103-10. doi: 10.1111/bjh.13267. Epub 2014 Dec 18. Br J Haematol. 2015. PMID: 25521756 Free article. Clinical Trial.
Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation.
Pascal L, Tucunduva L, Ruggeri A, Blaise D, Ceballos P, Chevallier P, Cornelissen J, Maillard N, Tabrizi R, Petersen E, Linkesch W, Sengeloev H, Kenzey C, Pagliuca A, Holler E, Einsele H, Gluckman E, Rocha V, Yakoub-Agha I; Eurocord and the European Society for Blood and Marrow Transplantation. Pascal L, et al. Among authors: tucunduva l. Blood. 2015 Aug 20;126(8):1027-32. doi: 10.1182/blood-2014-09-599241. Epub 2015 Jul 9. Blood. 2015. PMID: 26160301 Free article.
Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis.
Saccardi R, Tucunduva L, Ruggeri A, Ionescu I, Koegler G, Querol S, Grazzini G, Lecchi L, Nanni Costa A, Navarrete C, Pouthiers F, Larghero J, Regan D, Freeman T, Bittencourt H, Kenzey C, Labopin M, Baudoux E, Rocha V, Gluckman E. Saccardi R, et al. Among authors: tucunduva l. Transfusion. 2016 Aug;56(8):2021-9. doi: 10.1111/trf.13661. Epub 2016 May 31. Transfusion. 2016. PMID: 27245270
Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center.
Ferreira AM, Pontes da Silva CA, Pereira AD, Szor RS, Medeiros da Fonseca ARB, Serpa MG, Xavier EM, Sampaio de Melo MK, Novis Y, Tucunduva L, Rocha V, Arrais-Rodrigues C. Ferreira AM, et al. Among authors: tucunduva l. Bone Marrow Transplant. 2018 Apr;53(4):503-506. doi: 10.1038/s41409-017-0068-2. Epub 2018 Jan 12. Bone Marrow Transplant. 2018. PMID: 29330403 No abstract available.
23 results